Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04525690 · ClinicalTrials.gov registry record · NA

Improving Inpatient Screening for Hepatitis C

A NA study of Hepatitis C, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
7,634
Enrollment target
1
Study location

NCT04525690 is a NA study of Hepatitis C that has completed, run by University of Pennsylvania. The registered enrollment target is 7,634 participants, above the 1,818-participant average among 106 other Hepatitis C trials with a reported enrollment target (320% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04525690, a NA study of Hepatitis C, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
7,634 participants
Enrollment target
1
Study location

Study Summary

This study will use a stepped-wedge cluster randomized clinical trial to evaluate a health system initiative to set defaults in the electronic health record admission order set to nudge inpatient hepatitis C (HCV) screening.

Conditions Studied

Interventions

  • BEHAVIORAL Nudge

Study Locations (1)

Pennsylvania

  • Penn Medicine - Philadelphia

Trial Details

FieldValue
Enrollment Target 7,634 participants
Start Date 2020-09-21
Est. Completion 2021-04-10
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT04525690

The ClinicalTrials.gov registry entry for NCT04525690 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7,634 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,818-participant average among 106 other Hepatitis C trials with a reported enrollment target (320% higher). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hepatitis C appearing as the primary indexed condition, and to 1 intervention - of which Nudge is the first listed.

NCT04525690 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04525690 about?

NCT04525690 is a clinical study titled "Improving Inpatient Screening for Hepatitis C". This study will use a stepped-wedge cluster randomized clinical trial to evaluate a health system initiative to set defaults in the electronic health record admission order set to nudge inpatient hepatitis C (HCV) screening.

What is the current status of trial NCT04525690?

This trial is currently completed. It is a NA study. The enrollment target is 7,634 participants. The study started on 2020-09-21. Estimated completion is 2021-04-10.

What conditions does trial NCT04525690 study?

This clinical trial studies the following conditions: Hepatitis C.

What interventions are being tested in trial NCT04525690?

The interventions under investigation include: Nudge (BEHAVIORAL).

Who is sponsoring clinical trial NCT04525690?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04525690 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hepatitis C

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.